North Carolina man claims bladder cancer the result of taking diabetes drug Actos
A North Carolina man is the latest to claim that taking the popular type 2 diabetes drug Actos led to his bladder cancer diagnosis. The man has taken the same route as a growing number of other Americans and filed a lawsuit against the makers of the drug and the companies responsible for marketing it in the U.S. He claims in his … [Read more...] about North Carolina man claims bladder cancer the result of taking diabetes drug Actos
Illinois woman’s death blamed on taking diabetes medication Actos
A recently filed lawsuit in a federal court claims that an Illinois woman died as a result of bladder cancer she developed while take the popular type 2 diabetes medication Actos. This is the latest lawsuit to claim that taking Actos resulted in serious health complications, namely bladder cancer. For some people who experience … [Read more...] about Illinois woman’s death blamed on taking diabetes medication Actos
New study highlights risk of hip fractures associated with Actos
The findings of a new study should provide even more caution to those taking or considering Actos as a means of lowering their body's glucose level. According to a study funded in part by the European Association for the Study of Diabetes, taking thiazolidinedione drugs like pioglitazone (Actos) and rosiglitazone instead of other … [Read more...] about New study highlights risk of hip fractures associated with Actos
Consumer Reports Gives Generic Actos a Thumbs Down
Consumer Reports is warning type 2 diabetics to stay away from generic versions of Actos (pioglitazone) that were just approved by the U.S. Food & Drug Administration (FDA). According to the publication, other diabetes drugs like metformin are a better option for most people, as they don't carry the same risks for bladder cancer … [Read more...] about Consumer Reports Gives Generic Actos a Thumbs Down
Bladder Cancer Risks Don’t Deter FDA from Approving First Generic Actos
In spite of serious concerns that Actos (pioglitazone) can cause bladder cancer and other serious side effects, the Food & Drug Administration (FDA) has approved the first generic version of the type 2 diabetes drug for sale in the U.S. According to a statement from the agency, Mylan Pharmaceuticals, based in Morgantown, West … [Read more...] about Bladder Cancer Risks Don’t Deter FDA from Approving First Generic Actos
Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent
Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth. According to a report from Healthday News, the … [Read more...] about Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent
Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer
National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of the estate of a Kentucky man who developed bladder cancer and subsequently died, allegedly due to the use of diabetes drug, Actos. The lawsuit names Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc., Takeda Pharmaceuticals North America, … [Read more...] about Estate of Kentucky Man Alleges Wrongful Death Due to Actos Bladder Cancer
Canadian Study Confirms Actos Bladder Cancer Risk
A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood that a patient will get … [Read more...] about Canadian Study Confirms Actos Bladder Cancer Risk
National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat
A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, to issues its own … [Read more...] about National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat
Health Canada Says Actos Raises Bladder Cancer Risks
Health Canada just announced that Type 2 diabetes drug, Actos, raises risks for bladder cancer. Actos maker, Takeda Canada, Inc., was part of the joint announcement. The statement followed a safety assessment announced last June by Health Canada, two days following release of a similar warning by the U.S. Food & Drug … [Read more...] about Health Canada Says Actos Raises Bladder Cancer Risks
